der, years of experience, practice setting and number of pregnant patients with RD seen per month), their opinion on pregnancy in RD patients (pre-conception status of RD and counseling, remission length before allowing pregnancy) and compatible RD drugs with pregnancy and lactation. Qualitative variables were analyzed using Chi-square or Fisher's exact tests, while quantitative variables were analyzed using Wilcoxon or Student t tests. A total score of answers per physician in accordance with EULAR/BSR guidelines was calculated. Univariate and multivariate analysis assessed the variables significantly associated with this score. P value <0.05 indicated statistical significance. Results: Thirty-nine (90.7%) rheumatologists participated in this survey. They had 22.2±11.6 years of practice. Ninety-four (41.4%) obstetricians participated in this survey. They had 26.0±12.8 years of practice. Figure 1 displays the percentage of physicians who consider the selected RD medications detrimental to/not compatible with fertility, pregnancy and breastfeeding. Average score of answers in accordance with EULAR/BSR guidelines was 0.654±0.154 and results were significantly different between specialties (p<0.001): rheumatologists scored between 0.41 and 1, with an average of 0.777±0.152 and obstetricians scored between 0.36 and 1 with an average of 0.603±0.124. Multivariable analysis showed that the scores reflecting adherence to recommendations were significantly associated with type of specialty (rheumatology v/s obstetrics) and number of pregnant patients with RD seen per month. Conclusions: Advices given to RD patients who plan on becoming pregnant in Lebanon vary largely, especially among the physicians' specialty and experience in RD, which highlights the urgency of disseminating the EULAR/BSR guidelines among rheumatologists and obstetricians alike. Background: Rheumatoid arthritis (RA) is an inflammatory and disabling disease whose expression and clinical course is influenced by gender. In developed countries the prevalence of RA is 0.5-1%, with a ratio 3:1 female:male. Comparative gender studies have shown that women have greater functional disability, disease activity and pain than men1. Objectives: The purpose of this study is to describe and compare the clinical and serological characteristics of a cohort of men with RA. Methods: A cross-sectional study was conducted in patients with established diagnosis of RA (American College of Rheumatology criteria 1988) from the Luis Vernaza Hospital and a private rheumatology center (CERER). The data included clinical manifestations, demographic data, comorbidities, habits, treatment, activity index DAS28-CRP, HAQ-DI disability index and the PHQ-9 questionnaire. The statistical program SPSS V. 22 was used to analyze the data and calculate frequencies, percentages, means, ranges, Spearman correlation and ANOVA coefficient. Statistical significance used was 0.05, with a 95% reliability. Results: A cohort of 50 men was compared with a control group of 50 women. Most men worked while women stayed at home (72% and 66%, respectively, p=0.000). Tobacco and alcohol were more common in men (34% vs 8% p=0.001 and 38% vs. 0% p=0.000 respectively). The delay in the first visit to the specialist was shorter in men than in women (24 vs 32 months) and they had a longer follow-up (55 vs 41 months). In clinical manifestations, women had greater fatigue (60% vs 30% p=0.003), weight loss (44% vs 20% p=0.010), loss of appetite (54% vs 12% p=0.000) and depression (60% vs 22% p=0
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der, years of experience, practice setting and number of pregnant patients with RD seen per month), their opinion on pregnancy in RD patients (pre-conception status of RD and counseling, remission length before allowing pregnancy) and compatible RD drugs with pregnancy and lactation. Qualitative variables were analyzed using Chi-square or Fisher's exact tests, while quantitative variables were analyzed using Wilcoxon or Student t tests. A total score of answers per physician in accordance with EULAR/BSR guidelines was calculated. Univariate and multivariate analysis assessed the variables significantly associated with this score. P value <0.05 indicated statistical significance. Results: Thirty-nine (90.7%) rheumatologists participated in this survey. They had 22.2±11.6 years of practice. Ninety-four (41.4%) obstetricians participated in this survey. They had 26.0±12.8 years of practice. Figure 1 displays Background: Rheumatoid arthritis (RA) is an inflammatory and disabling disease whose expression and clinical course is influenced by gender. In developed countries the prevalence of RA is 0.5-1%, with a ratio 3:1 female:male. Comparative gender studies have shown that women have greater functional disability, disease activity and pain than men1. Objectives: The purpose of this study is to describe and compare the clinical and serological characteristics of a cohort of men with RA. Methods: A cross-sectional study was conducted in patients with established diagnosis of RA (American College of Rheumatology criteria 1988) from the Luis Vernaza Hospital and a private rheumatology center (CERER). The data included clinical manifestations, demographic data, comorbidities, habits, treatment, activity index DAS28-CRP, HAQ-DI disability index and the PHQ-9 questionnaire. The statistical program SPSS V. 22 was used to analyze the data and calculate frequencies, percentages, means, ranges, Spearman correlation and ANOVA coefficient. Statistical significance used was 0.05, with a 95% reliability. Results: A cohort of 50 men was compared with a control group of 50 women. Most men worked while women stayed at home (72% and 66%, respectively, p=0.000). Tobacco and alcohol were more common in men (34% vs 8% p=0.001 and 38% vs. 0% p=0.000 respectively). The delay in the first visit to the specialist was shorter in men than in women (24 vs 32 months) and they had a longer follow-up (55 vs 41 months). In clinical manifestations, women had greater fatigue (60% vs 30% p=0.003), weight loss (44% vs 20% p=0.010), loss of appetite (54% vs 12% p=0.000) and depression (60% vs 22% p=0.000). There was no significant difference in comorbidities and treatment between the groups. Men had lower disease activity: VSG (23 vs 47 p=0.046), DAS 28 (2.5 vs 3.4 p=0.011), HAQ DI (0.37 vs 1.12 p=0.000), functional disability (12% vs 36% p=0.005), severe disability (2% vs 22% p=0.002), painful joints (2 vs 8 p=0.000), swollen joints (2 vs 6 p=0.000) and VAS of doctor (2 vs 3 p=0.047). Conclusions: This is the first cohort study of men with RA in Ecuador. As shown in other international studies2-3, our results confirm that men have a less aggressive disease. Background: Rheumatoid arthritis (RA) is associated with several comorbidities that reduce life expectancy. These comorbidities may be due to the rheumatic process itself, treatment or be independent, and include: anemia, osteoporosis, fractures, infections, gastric ulcers, myocardial infarction, depression, lymphoma and other malignancies. Objectives: The aim of this study is to determine the comorbidities in patients with an establish diagnosis of rheumatoid arthritis. Methods: A cross-sectional descriptive study was conducted in patients with an established diagnosis of RA according to the ACR 1987 criteria, from public and private rheumatology clinics in Guayaquil, Ecuador. The database included; demographics, comorbidities, habits, treatments, laboratory exams, number of swollen and tender joints, Visual Analog Scale (VAS), activity and disability index (DAS28 and HAQ-DI) and PHQ-9 for depression. The statistical program SPSS V. 22 was used to analyze the data and calculate frequencies, percentages, means, ranges, Spearman correlation and ANOVA coefficient. Statistical significance used was 0.05, with a 95% reliability. Results: 402 patients with a mean age of 50 years were included, 87.8% (353) women and 12.2% (49) men. 93.8% (377) were mestizos, 3.5% (14) White, 1.5% (6) Indigenous and 1.2% (5) Afro-Ecuadorians. As for the marital status 55.5% (223) were married, 15.4% (62) cohabiting, 12.4% (50) divorced, 8.5% (34) singles and 8.2% (33) widowers. 9.7% (39) of the patients smoked, 7.5% (30) ingested alcohol and 0.5% (2) drugs. The average age of onset of the disease was 41 years, with a median time from onset of symptoms and the first rheumatology visit of 28.7 months, median follow-up time of 51.8 months and average disease duration of 11 years. For comorbidities, 54.8% (147/268) had dyslipidemia, 28.4% (114) gastric disease, 23.6% (95) hypertension, 20.1% (81) obesity, 19.6% (79) depression, 15.2% (61) thyroid disease, 12.4% (50) of the sexual involvement, 10.7% (43) allergies, 10.4% (32/307) hypertransaminasemia, 9.3% (21/225) anemia, and 6.7% (27) diabetes mellitus. 32.3% (114) of women have had at least one abortion. The PHQ-9 medium was 5.3; according to this 11.2% (45) corresponded to mild depression, 4.5% (18) moderate depression, 3.2% (13) moderately severe depression and 0.7% (3) severe depression. As for the other indicators of disease activity, the average for the number of painful joints was 5 (0-28), swollen joints 4 (0-26), patient VAS 3.9 (0-10) and doctor VAS 3.4 (0-10). In laboratory data, 67.4% (215/319) had positive ESR, 64.8% (149/230) PCR, 90.5% (182/201) anti CCP positive, and 94.4% (286/303) RF. Conclusions: This is the first study of comorbidities in patients with RA in Ecuador. Patients with RA have a high prevalence of comorbidities and risk factors, which is why physicians should be prepared to prevent them and offer an early treatment. Disclosure of Interest: None declared DOI: 10.1136/annrheumdis-2017-eular.1408
